Nader Marc-Elie, Gidley Paul W
Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
J Neurol Surg B Skull Base. 2019 Apr;80(2):214-224. doi: 10.1055/s-0039-1677865. Epub 2019 Feb 4.
Radiation and chemotherapy are frequently used in the treatment of head and neck malignancies. Ototoxicity is a common adverse effect of these treatment modalities. This article discusses the patterns of hearing loss following chemotherapy and radiation therapy. Specific issues related to hearing rehabilitation in oncological patients will also be covered, such as controversies regarding treatment of radiation-induced serous otitis media, risks of otologic surgery, and the use of osseointegrated hearing aids and cochlear implants.
放射治疗和化疗常用于头颈部恶性肿瘤的治疗。耳毒性是这些治疗方式常见的不良反应。本文讨论化疗和放射治疗后听力损失的模式。还将涵盖与肿瘤患者听力康复相关的具体问题,例如关于放射性浆液性中耳炎治疗的争议、耳科手术的风险以及骨锚式助听器和人工耳蜗的使用。